Get the content you want anytime you want.

As HIV Drug Resistance Grows, WHO Calls for Global Action

WHO also announced that they are developing “new tools to help countries monitor HIV drug resistance, improve the quality of treatment programs, and transition to new HIV treatments, if needed.”

The new guidelines and reports will be presented at the upcoming International AIDS Society Conference in Paris: 9th IAS Conference on HIV Science.

In addition, WHO is also releasing 7 Key Guidelines and normative tools, as follows :
  1. A new information note on point-of-care early infant diagnosis assays to support the timely detection of children with HIV.
  2. The results of “STAR-self-testing in Africa” an implementation research effort, together with a new landscape report on rapid diagnostic tests for HIV self-testing.
  3. A prioritized research agenda for children and adolescents to address low treatment scale-up and quality care for this group.
  4. New guidelines on advanced HIV disease and rapid initiation of ART recommending screening, treatment and prophylaxis for major opportunistic infections (such as tuberculosis and cryptococcal disease), and rapid initiation of ART and adherence support for people with advanced HIV.
  5. A new report outlining how countries can provide differentiated care tailored services for different needs of patient groups.
  6. A new technical update advising countries on what to consider when transitioning to a new treatment regimen, including dolutegravir.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.